Evidence map›Paper›PMID 42818947›Full record

ArticleResearch square2026

Separating ECog scale-score information from dyad availability: observation-process contributions to dyadic prediction of cognitive impairment in ADNI.

Wan Kiu Winkey Cheng, Alzheimer’s Disease Neuroimaging Initiative

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wan Kiu Winkey ChengDepartment of Biomedical Engineering, College of Biomedicine, City University of Hong Kong, Kowloon Tong, Hong Kong SAR, China.ORCID 0009-0009-7557-4272
Alzheimer’s Disease Neuroimaging Initiative

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Self- and informant-reported cognitive concerns are common, but their apparent incremental discriminative contribution can be inflated when missingness is structured by study protocol and assessment era. We tested the hypothesis that dyadic ECog would improve discrimination beyond conventional predictors, but that this increment would be attenuated after accounting for dyad availability and protocol-structured missingness. Methods: We included 1,643 cognitively unimpaired (CU) participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI; 221 events: 213 mild cognitive impairment [MCI], 8 Alzheimer's disease [AD] dementia) and fit nested cross-validated elastic-net Cox models with fold-wise imputation. Results: The conventional model (M2) concordance index (C-index) was 0.680, but fell to 0.649 when missingness indicators were removed. M3 (M2 plus dyadic Everyday Cognition (ECog) mean and dyad availability) reached 0.758; after accounting for dyad availability, ECog scale scores showed a modest contribution beyond availability (ΔC = 0.026, 95% confidence interval (CI) 0.007 to 0.045), whereas the score-only comparison provided limited evidence for an independent contribution (ΔC = 0.010, 95% CI -0.004 to 0.024). In an inverse-probability-of-censoring-weighted (IPCW) sensitivity analysis, ΔC was 0.105 (95% CI 0.050 to 0.174). Conclusions: In this ADNI analysis, missingness-indicator imputation may increase the apparent discriminative contribution of dyadic measures; much of the observed gain was associated with dyad availability, and limited evidence was found for an independent contribution from ECog scale scores.

Indexed as

dyadic informant reportECogprognostic modelsubjective cognitive decline

Identifiers

PMID42818947
PMCPMC13622837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.